Chest Pain clinical trials

Explore recruiting chest pain clinical trials.

Recruiting chest pain studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chest Pain trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Effect of citalopram on chest pain in patients with achalasia.

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 3 Study of Pembrolizumab in Combination With Carboplatin/Taxane (Paclitaxel or Nab-paclitaxel) followed by Pembrolizumab With or Without Maintenance MK-2870 in the First-line Treatment of Metastatic Squamous Non-small Cell Lung Cancer

Italy, Czechia, Ireland, Germany, France, Spain +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

MAMI Use of the Methoxyflurane as pain-killer in the prehospital management of Acute Myocardial Infarction

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

MAMI Use of the Methoxyflurane as pain-killer in the prehospital management of Acute Myocardial Infarction

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Open-label, Phase 3 Study of MK-2870 in Combination With Pembrolizumab Compared to Pembrolizumab Monotherapy in the First-line Treatment of Participants With Metastatic Non-small Cell Lung Cancer With PD-L1 TPS Greater than or Equal to 50% (TroFuse-007)

Portugal, France, Italy, Germany, Spain, Netherlands +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3 Study of Pembrolizumab in Combination with Carboplatin/Taxane (Paclitaxel or Nab-paclitaxel) Followed by Pembrolizumab with or without Maintenance Olaparib in the First-line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Germany, Austria, Spain, France, Poland, Romania

Therapeutic confirmatory (Phase III) EU CTIS Study details

Chest Pain trials by city

Chest Pain in Toronto Chest Pain in Vancouver Chest Pain in Montreal Chest Pain in Calgary Chest Pain in Edmonton Chest Pain in Ottawa Chest Pain in Winnipeg Chest Pain in Quebec City Chest Pain in Hamilton Chest Pain in Kitchener Chest Pain in London Chest Pain in Halifax Chest Pain in New York Chest Pain in Los Angeles Chest Pain in Chicago Chest Pain in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease